These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23697478)

  • 1. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease.
    Altowaijri A; Phillips CJ; Fitzsimmons D
    J Manag Care Pharm; 2013 Jun; 19(5):408-16. PubMed ID: 23697478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis.
    Dawoud DM; Smyth M; Ashe J; Strong T; Wonderling D; Hill J; Varia M; Dyer P; Bion J
    Res Social Adm Pharm; 2019 Oct; 15(10):1212-1222. PubMed ID: 30389320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted Pharmacist-led Interventions in the Hospital Setting: A Systematic Review.
    Skjøt-Arkil H; Lundby C; Kjeldsen LJ; Skovgårds DM; Almarsdóttir AB; Kjølhede T; Duedahl TH; Pottegård A; Graabaek T
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):363-379. PubMed ID: 29723934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
    Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
    J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
    Santschi V; Chiolero A; Burnand B; Colosimo AL; Paradis G
    Arch Intern Med; 2011 Sep; 171(16):1441-53. PubMed ID: 21911628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.
    Mc Namara KP; George J; O'Reilly SL; Jackson SL; Peterson GM; Howarth H; Bailey MJ; Duncan G; Trinder P; Morabito E; Finch J; Bunker S; Janus E; Emery J; Dunbar JA
    BMC Health Serv Res; 2010 Sep; 10():264. PubMed ID: 20819236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.
    Carter BL; Levy B; Gryzlak B; Xu Y; Chrischilles E; Dawson J; Vander Weg M; Christensen A; James P; Polgreen L
    Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004188. PubMed ID: 29884657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
    Nkansah N; Mostovetsky O; Yu C; Chheng T; Beney J; Bond CM; Bero L
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000336. PubMed ID: 20614422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
    Warden BA; Shapiro MD; Fazio S
    Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
    [No Abstract]   [Full Text] [Related]  

  • 16. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.
    Amariles P; Sabater-Hernández D; García-Jiménez E; Rodríguez-Chamorro MÁ; Prats-Más R; Marín-Magán F; Galán-Ceballos JA; Jiménez-Martín J; Faus MJ
    J Manag Care Pharm; 2012 May; 18(4):311-23. PubMed ID: 22548691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacists and inpatient medical care: a systematic review.
    Kaboli PJ; Hoth AB; McClimon BJ; Schnipper JL
    Arch Intern Med; 2006 May; 166(9):955-64. PubMed ID: 16682568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.